Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,536 studies match

clinicaltrialsPublishedShowing 201–250 of 1,536 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04619004	HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer	active not recruiting	Phase 2	277	Daiichi SankyoINDUSTRY	16	Sep 1, 2026	clinicaltrials
NCT05508867	A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Physician's Choice Chemotherapy in PD-(L)1-refractory, Relapsed or Refractory Classical Hodgkin Lymphoma (MK-4280A-008)	completed	Phase 2	203	Merck Sharp & Dohme LLCINDUSTRY	20	Sep 1, 2026